Association of genetic variants of the chemokine receptor CCR5 and its ligands, RANTES and MCP-2, with outcome of HCV infection - PubMed (original) (raw)
. 2003 Dec;38(6):1468-76.
doi: 10.1016/j.hep.2003.09.027.
Angela J Frodsham, Branwen J W Hennig, Paul Klenerman, Suzanne Knapp, Patricia Ramaley, Jack Satsangi, Mark Wright, Lyna Zhang, Howard C Thomas, Mark Thursz, Adrian V S Hill
Affiliations
- PMID: 14647058
- DOI: 10.1016/j.hep.2003.09.027
Association of genetic variants of the chemokine receptor CCR5 and its ligands, RANTES and MCP-2, with outcome of HCV infection
Simon Hellier et al. Hepatology. 2003 Dec.
Abstract
The effect of host genetic variation on the outcome of hepatitis C virus (HCV) infection and its treatment is poorly understood. The chemokine receptors CCR5, CCR2, and CCR3 and their ligands, RANTES, MCP-1, MCP-2, and MIP-1alpha, are involved in the immune responses and the selective recruitment of lymphocytes to the liver in HCV infection. We studied 20 polymorphisms within these genes and investigated their association with persistent carriage of HCV, severity of liver disease, hepatic inflammation, and response to treatment in a large European cohort. Significant associations were found between CCR5-delta32 and reduced portal inflammation (P =.011, odds ratio [OR]: 2.3, 95% confidence interval [CI]: 1.09-4.84) and milder fibrosis (P =.015, OR: 1.97, 95% CI: 1.13-3.42). A promoter polymorphism at position -403 in the RANTES gene was associated with less severe portal inflammation (P =.004). An amino acid change in MCP2, Q46K, was associated with severity of fibrosis (P =.018, OR: 2.29, 95% CI: 1.14-4.58). In conclusion, our study suggests a possible role of the polymorphisms CCR5-delta32, RANTES -403, and MCP-2 Q46K in the outcome of HCV infection.
Comment in
- Chemokine systems and hepatitis C virus infection: is truth in the genes of the beholders?
Promrat K, Liang TJ. Promrat K, et al. Hepatology. 2003 Dec;38(6):1359-62. doi: 10.1016/j.hep.2003.10.008. Hepatology. 2003. PMID: 14647045 No abstract available.
Similar articles
- The CCR5-delta32 mutation: impact on disease outcome in individuals with hepatitis C infection from a single source.
Goulding C, McManus R, Murphy A, MacDonald G, Barrett S, Crowe J, Hegarty J, McKiernan S, Kelleher D. Goulding C, et al. Gut. 2005 Aug;54(8):1157-61. doi: 10.1136/gut.2004.055699. Epub 2005 Apr 29. Gut. 2005. PMID: 15863470 Free PMC article. - Associations of chemokine system polymorphisms with clinical outcomes and treatment responses of chronic hepatitis C.
Promrat K, McDermott DH, Gonzalez CM, Kleiner DE, Koziol DE, Lessie M, Merrell M, Soza A, Heller T, Ghany M, Park Y, Alter HJ, Hoofnagle JH, Murphy PM, Liang TJ. Promrat K, et al. Gastroenterology. 2003 Feb;124(2):352-60. doi: 10.1053/gast.2003.50061. Gastroenterology. 2003. PMID: 12557141 - Chemokine systems and hepatitis C virus infection: is truth in the genes of the beholders?
Promrat K, Liang TJ. Promrat K, et al. Hepatology. 2003 Dec;38(6):1359-62. doi: 10.1016/j.hep.2003.10.008. Hepatology. 2003. PMID: 14647045 No abstract available. - The role of chemokines as inflammatory mediators in chronic hepatitis C virus infection.
Zeremski M, Petrovic LM, Talal AH. Zeremski M, et al. J Viral Hepat. 2007 Oct;14(10):675-87. doi: 10.1111/j.1365-2893.2006.00838.x. J Viral Hepat. 2007. PMID: 17875002 Review. - CCR5 plays important roles in hepatitis B infection.
Sanchooli J, Sanadgol N, Kazemi Arababadi M, Kennedy D. Sanchooli J, et al. Viral Immunol. 2014 Feb;27(1):2-6. doi: 10.1089/vim.2013.0067. Epub 2014 Jan 9. Viral Immunol. 2014. PMID: 24405101 Review.
Cited by
- A CCL5 Haplotype Is Associated with Low Seropositivity Rate of HCV Infection in People Who Inject Drugs.
Huik K, Avi R, Pauskar M, Kallas E, Jõgeda EL, Karki T, Rüütel K, Talu A, Abel-Ollo K, Uusküla A, Carrillo A, Ahuja SK, He W, Lutsar I. Huik K, et al. PLoS One. 2016 Jun 15;11(6):e0156850. doi: 10.1371/journal.pone.0156850. eCollection 2016. PLoS One. 2016. PMID: 27304910 Free PMC article. - Diclofenac Disrupts the Circadian Clock and through Complex Cross-Talks Aggravates Immune-Mediated Liver Injury-A Repeated Dose Study in Minipigs for 28 Days.
Selvaraj S, Oh JH, Yoon S, Borlak J. Selvaraj S, et al. Int J Mol Sci. 2023 Jan 11;24(2):1445. doi: 10.3390/ijms24021445. Int J Mol Sci. 2023. PMID: 36674967 Free PMC article. - Role of host genetic factors in the outcome of hepatitis C virus infection.
Bengsch B, Thimme R, Blum HE. Bengsch B, et al. Viruses. 2009 Sep;1(2):104-125. doi: 10.3390/v1020104. Epub 2009 Aug 5. Viruses. 2009. PMID: 21994541 Free PMC article. - Stem cell-based therapies for HIV/AIDS.
Pernet O, Yadav SS, An DS. Pernet O, et al. Adv Drug Deliv Rev. 2016 Aug 1;103:187-201. doi: 10.1016/j.addr.2016.04.027. Epub 2016 May 2. Adv Drug Deliv Rev. 2016. PMID: 27151309 Free PMC article. Review. - Pseudogenization of the MCP-2/CCL8 chemokine gene in European rabbit (genus Oryctolagus), but not in species of Cottontail rabbit (Sylvilagus) and Hare (Lepus).
van der Loo W, Afonso S, de Matos AL, Abrantes J, Esteves PJ. van der Loo W, et al. BMC Genet. 2012 Aug 15;13:72. doi: 10.1186/1471-2156-13-72. BMC Genet. 2012. PMID: 22894773 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous